Cargando…
Microbial Fibrinolytic Enzymes as Anti-Thrombotics: Production, Characterisation and Prodigious Biopharmaceutical Applications
Cardiac disorders such as acute myocardial infarction, embolism and stroke are primarily attributed to excessive fibrin accumulation in the blood vessels, usually consequential in thrombosis. Numerous methodologies including the use of anti-coagulants, anti-platelet drugs, surgical operations and fi...
Autores principales: | Sharma, Chhavi, Osmolovskiy, Alexander, Singh, Rajni |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8625737/ https://www.ncbi.nlm.nih.gov/pubmed/34834294 http://dx.doi.org/10.3390/pharmaceutics13111880 |
Ejemplares similares
-
Fibrin and Fibrinolytic Enzyme Cascade in Thrombosis: Unravelling the Role
por: Singh, Rajni, et al.
Publicado: (2023) -
Computational-approach understanding the structure-function prophecy of Fibrinolytic Protease RFEA1 from Bacillus cereus RSA1
por: Sharma, Chhavi, et al.
Publicado: (2021) -
Chicken Feather Waste Valorization Into Nutritive Protein Hydrolysate: Role of Novel Thermostable Keratinase From Bacillus pacificus RSA27
por: Sharma, Chhavi, et al.
Publicado: (2022) -
Thrombolytic Potential of Novel Thiol-Dependent Fibrinolytic Protease from Bacillus cereus RSA1
por: Sharma, Chhavi, et al.
Publicado: (2019) -
Urinary pro-thrombotic, anti-thrombotic, and fibrinolytic molecules as biomarkers of lupus nephritis
por: Qin, Ling, et al.
Publicado: (2019)